Regeneron Pharmaceuticals (REGN)
Income Tax Expense
$230.90M
Quarterly · Period ending: · USD
REGN Income Tax Expense
Latest reported$230.90Mperiod ending
Latest reported$230.90Mperiod ending
REGN Quarterly Income Tax ($0.00 → $230.90M)
Quarterly income tax expense
High-resolution chart · PNG
REGN income tax expense history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Income Tax Expense (USD) |
|---|---|
| 230,900,000 | |
| 104,000,000 | |
| 199,100,000 | |
| 303,300,000 | |
| 127,100,000 | |
| 96,300,000 | |
| 40,400,000 | |
| 152,400,000 | |
| 195,800,000 | |
| -21,300,000 | |
| -12,000,000 | |
| 103,000,000 | |
| 114,500,000 | |
| 40,200,000 | |
| 127,600,000 | |
| 194,100,000 | |
| 111,100,000 | |
| 87,600,000 | |
| 274,400,000 | |
| 184,400,000 | |
| 653,900,000 | |
| 137,800,000 | |
| 75,400,000 | |
| 156,200,000 | |
| 21,600,000 | |
| 44,000,000 | |
| 97,800,000 | |
| 98,900,000 | |
| 31,600,000 | |
| 85,000,000 | |
| -144,200,000 | |
| 41,206,000 | |
| 104,662,000 | |
| 107,418,000 | |
| 381,248,000 | |
| 177,288,000 | |
| 138,106,000 | |
| 183,358,000 | |
| 88,412,000 | |
| 101,077,000 | |
| 96,038,000 | |
| 164,415,000 | |
| 72,295,000 | |
| 182,891,000 | |
| 133,353,000 | |
| 200,502,000 | |
| 111,111,000 | |
| 96,358,000 | |
| 110,384,000 | |
| 109,820,000 | |
| 101,347,000 | |
| 84,378,000 | |
| 60,316,000 | |
| 42,957,000 | |
| -335,848,000 | |
| -517,000 | |
| -501,000 | |
| 0 | |
| -615,000 | |
| 562,000 | |
| -863,000 | |
| -216,000 | |
| 846,000 | |
| -906,000 | |
| -1,184,000 | |
| 218,000 | |
| -4,122,000 | |
| 0 | |
| 0 | |
| -3,500,000 | |
| -728,000 | |
| 3,079,000 | |
| -4,534,000 | |
| -11,597,000 | |
| 64,000 | |
| -8,669,000 | |
| -10,671,000 | |
| -10,475,000 | |
| -2,515,000 | |
| 0 | |
| -673,000 | |
| -1,283,000 | |
| 246,121,000 | |
| -2,481,000 | |
| -13,347,000 | |
| -51,447,000 | |
| -650,000 | |
| 180,000 | |
| 801,000 | |
| -84,612,000 | |
| 1,370,000 | |
| 412,000 | |
| 703,000 | |
| 523,000 | |
| -675,000 | |
| -1,737,000 | |
| -2,081,000 | |
| -2,518,000 | |
| -3,901,000 | |
| -6,525,000 |